Page 23 - Read Online

Page 14 of 15 Chen et al. Cancer Drug Resist 2024;7:9 https://dx.doi.org/10.20517/cdr.2023.151

11. André T, Shiu KK, Kim TW, et al; KEYNOTE-177 Investigators. Pembrolizumab in microsatellite-instability-high advanced
colorectal cancer. N Engl J Med 2020;383:2207-18. DOI PubMed
12. Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science
2017;357:409-13. DOI PubMed PMC
13. Schrock AB, Ouyang C, Sandhu J, et al. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-
high metastatic colorectal cancer. Ann Oncol 2019;30:1096-103. DOI
14. Kwon M, An M, Klempner SJ, et al. Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-
high gastric cancer. Cancer Discov 2021;11:2168-85. DOI PubMed
15. Corti F, Lonardi S, Intini R, et al. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer
patients treated with immune checkpoint inhibitors. Eur J Cancer 2021;150:155-67. DOI PubMed
16. Laubach K, Turan T, Mathew R, Wilsbacher J, Engelhardt J, Samayoa J. Tumor-intrinsic metabolic reprogramming and how it drives
resistance to anti-PD-1/PD-L1 treatment. Cancer Drug Resist 2023;6:611-41. DOI PubMed PMC
17. Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett 2015;365:141-8. DOI
18. Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol 2017;14:992-9. DOI PubMed
PMC
19. Zeng Y, Du W, Huang Z, et al. Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging
miR-1205. Cell Death Discov 2023;9:153. DOI PubMed PMC
20. Liu P, Wang Z, Ou X, et al. The FUS/circEZH2/KLF5/feedback loop contributes to CXCR4-induced liver metastasis of breast cancer
by enhancing epithelial-mesenchymal transition. Mol Cancer 2022;21:198. DOI PubMed PMC
21. Wu J, Zhu MX, Li KS, Peng L, Zhang PF. Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/
SOX4 axis in non-small cell lung cancer. Cancer Drug Resist 2022;5:261-70. DOI PubMed PMC
22. Chen N, Hu Y, Huang RZ, Chen DL. Circular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by
regulating ZEB2. J Gastroenterol Hepatol 2023;38:1181-91. DOI PubMed
23. Chen DL, Wang DS, Wu WJ, et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and
metastasis in colorectal cancer. Carcinogenesis 2013;34:803-11. DOI PubMed PMC
24. Chen DL, Lu YX, Zhang JX, et al. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA
for microRNA-215 to regulate ZEB2 expression. Theranostics 2017;7:4836-49. DOI PubMed PMC
25. Chen DL, Sheng H, Zhang DS, et al. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance
through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer 2021;20:166. DOI PubMed PMC
26. Zeng Y, Li B, Liang Y, et al. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-
bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J 2019;33:6596-608. DOI PubMed PMC
27. Zhou R, Wu Y, Wang W, et al. Circular RNAs (circRNAs) in cancer. Cancer Lett 2018;425:134-42. DOI
28. Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer 2019;18:6. DOI PubMed PMC
29. Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol 2016;17:205-11. DOI PubMed
30. Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH. CircRNAs and cancer: biomarkers and master regulators. Semin
Cancer Biol 2019;58:90-9. DOI PubMed
31. Ding N, You AB, Yang H, et al. A tumor-suppressive molecular axis EP300/circRERE/miR-6837-3p/MAVS activates type I IFN
pathway and antitumor immunity to suppress colorectal cancer. Clin Cancer Res 2023;29:2095-109. DOI PubMed PMC
32. Kolijn K, Verhoef EI, Smid M, et al. Epithelial-mesenchymal transition in human prostate cancer demonstrates enhanced immune
evasion marked by IDO1 expression. Cancer Res 2018;78:4671-9. DOI PubMed
33. Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular RNA circ-CPA4/let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug
resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res 2020;39:149. DOI PubMed PMC
34. Spranger S. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.
Int Immunol 2016;28:383-91. DOI PubMed PMC
35. Wu AA, Drake V, Huang HS, Chiu S, Zheng L. Reprogramming the tumor microenvironment: tumor-induced immunosuppressive
factors paralyze T cells. Oncoimmunology 2015;4:e1016700. DOI PubMed PMC
36. Dasanu CA, Alani M, Habibi S, Codreanu I. Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired
microsatellite instability: current state and future directions. J Oncol Pharm Pract 2023:10781552231178293. DOI PubMed
37. Gong J, Wang C, Lee PP, Chu P, Fakih M. Response to PD-1 blockade in microsatellite stable metastatic colorectal cancer harboring a
POLE mutation. J Natl Compr Canc Netw 2017;15:142-7. DOI PubMed
38. Adeleke S, Haslam A, Choy A, et al. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from
a case report and how to avoid such pitfalls. Per Med 2022;19:277-86. DOI
39. Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 2016;17:272-83. DOI
PubMed
40. Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell 2013;51:792-806. DOI
41. Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 2015;22:256-64.
DOI
42. Zhou Y, Xue X, Luo J, et al. Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma
progression by stabilizing GLI2 mRNA. Cancer Sci 2023;114:3608-22. DOI PubMed PMC